BRKR
NASDAQ
US
Bruker Corporation - Common Stock
$36,76
▲ +$0,68
(+1,88%)
Vol. 1.5M
6
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$7.2B
ROE
-1,1%
Margine
-0,6%
D/E
82,59
Beta
1,17
Rendimento div.
0,42%
52W
$29–$65
Consenso Wall Street
22 analisti · Apr 20267
Acquisto forte
8
Compra
6
Mantieni
1
Vendi
0
Vendita forte
68,2%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,66 | $0,59 | $-0,07 |
| Set 2025 | $0,34 | $0,45 | +$0,11 |
| Giu 2025 | $0,43 | $0,32 | $-0,11 |
| Mar 2025 | $0,44 | $0,47 | +$0,03 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $979.6M | $801.4M | $797.4M | $860.5M | $977.2M |
| Utile netto | — | $13.7M | $17.4M | $7.6M | -$59.6M | $26.0M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 4.4% | 4.4% | 4.4% | 4.4% | -1.1% | -1.1% |
| P/E (TTM) | 78.43 | 64.97 | 65.26 | 74.22 | — | — |
| Net Margin | 0.9% | 2.3% | 2.3% | 2.3% | -0.6% | -0.6% |
| Gross Margin | 45.4% | 48.5% | 48.5% | 48.5% | 48.0% | 48.0% |
| D/E Ratio | 134.99 | 134.99 | 134.99 | 134.99 | 82.59 | 82.59 |
| Current Ratio | 1.61 | 1.61 | 1.61 | 1.61 | 1.85 | 1.85 |
Rapporti chiave
ROA (TTM)
-0,3%
P/S (TTM)
2,08
P/B
5,0
EPS (TTM)
$-0,14
CF/Share
$2,86
Crescita ricavi 3A
+11,7%
52W High
$64,64
52W Low
$28,53
$28,53
Intervallo 52 settimane
$64,64
Salute finanziaria
Flusso di cassa libero
$177.8M
Debito netto
$1.7B
Liquidità
$298.8M
Debito totale
$2.0B
Aggiornato al Dic 31, 2025
Як BRKR виглядає на тлі конкурентів у Life Sciences Tools & Services?
Група порівняння: Small-cap Life Sciences Tools & Services ($300M+) · 25 компаній
Оцінка BRKR vs аналоги Life Sciences Tools & Services
P/E
—
▼
0%
sotto
peer
(32,5)
vs Peer
vs Settore
Valore equo
P/S
2,1
▼
46%
sotto
peer
(3,8)
vs Peer
vs Settore
Sottovalutato
P/B
5,0
▲
34%
sopra
peer
(3,7)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
0,4%
▼
12%
sotto
peer
(0,5%)
vs Peer
vs Settore
Rendimento basso
Прибутковість BRKR vs аналоги Life Sciences Tools & Services
ROE
-1,1%
▲
67%
sopra
peer
(-3,3%)
vs Peer
vs Settore
Sotto media
Net margin
-0,6%
▲
94%
sopra
peer
(-9,4%)
vs Peer
vs Settore
Sotto media
Валова маржа
48,0%
▲
0%
sopra
peer
(48,0%)
vs Peer
vs Settore
In linea
ROA
-0,3%
▲
87%
sopra
peer
(-2,6%)
vs Peer
vs Settore
Sotto media
Фінансове здоровʼя BRKR vs аналоги Life Sciences Tools & Services
D/E ratio
82,6
▲
126%
sopra
peer
(36,5)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
1,9
▼
45%
sotto
peer
(3,4)
vs Peer
vs Settore
Liquidità bassa
Beta
1,2
▼
17%
sotto
peer
(1,4)
vs Peer
vs Settore
Più volatile
Радар фундаменталів BRKR
BRKR
Mediana peer
Industria
BRKR прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
BRKR vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
MUNCH MARK ROBERT
Officer · Mar 13
2000 shs
MUNCH MARK ROBERT
Officer · Mar 13
2000 shs
ROSENTHAL ROBERT JOHN
Director · Feb 13
4520 shs
PACKER RICHARD A
Director · Feb 13
4520 shs
LINTON WILLIAM A.
Director · Feb 13
4520 shs
ORNELL JOHN A
Director · Feb 13
4520 shs
FRANCIS LAURA A.
Director · Feb 13
4520 shs
PERKINS ADELENE QUIGLEY
Director · Feb 13
4520 shs
ANDERSON BONNIE H
Director · Feb 13
4520 shs
REQUARDT HERMANN FRITZ
Director · Feb 13
4520 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 39,98%FMR, LLC
10,01%
$513.5M
Orbis Allan Gray Ltd
9,79%
$502.7M
Blackrock Inc.
7,21%
$370.0M
Vanguard Group Inc
6,74%
$346.0M
Pallas Capital Advisors Llc
6,23%
$319.7M
Aggiornato al Dic 31, 2025
Dividendi
$0,20
/ anno
Mar 23, 2026
$0,0500
Dic 08, 2025
$0,0500
Set 23, 2025
$0,0500
Giu 16, 2025
$0,0500
Mar 17, 2025
$0,0500
Dic 02, 2024
$0,0500
Ago 30, 2024
$0,0500
Giu 03, 2024
$0,0500